Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Efficacy and Safety of Peginterferon Beta-1A Compared to Interferon Beta-1A in Relapsing Remitting Multiple Sclerosis Patients: A Phase 3, Randomized, Non-Inferiority Clinical Trial (Pegintegrity)
Seyed Ehsan Mohammadianinejad
Seyed Ehsan Mohammadianinejad

Associate Professor of Neurology

Department Neurology

School of Medicine

Tehran University of Medical Sciences

All Documents
1. Cognitive Reserve and Its Contribution to Predicting Cognitive Performance in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2026)
2. Extended Interval Dosing of Off-Label Rituximab in Multiple Sclerosis: A Real-World Retrospective Analysis of Clinical Efficacy and Safety, Multiple Sclerosis and Related Disorders (2026)
3. Brief International Cognitive Assessment for Multiple Sclerosis (Bicams): Iranian Normative Values and Correlates of Cognitive Function, Clinical Neurology and Neurosurgery (2025)
4. Neurological Complications of Paget’S Disease of Bone; a Narrative Overview, Journal of Parathyroid Disease (2025)
5. The Effect of Atomoxetine Efficacy on Freezing of Gait in Patient With Parkinson’S Disease: A Double-Blinded Randomized Clinical Trial, Immunopathologia Persa (2025)
6. Anticoagulation in the Management of Septic Cavernous Sinus Thrombosis Secondary to Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Real-World Experience, Current Journal of Neurology (2024)
7. Early Growth Response 1 Transcription Factor and Its Context-Dependent Functions in Glioblastoma, Wspolczesna Onkologia (2024)
8. Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis: A Phase Iii, Randomized, Equivalency, Clinical Trial, Scientific Reports (2024)
9. Evaluating Efficacy and Safety of Ocrelizumab Biosimilar (Xacrel) Compared to the Originator (Ocrevus) in Relapsing Multiple Sclerosis: A Phase Iii, Randomized, Equivalency, Clinical Trial, Scientific Reports (2024)
10. New Diagnosis of Multiple Sclerosis in the Setting of Recent Sinopharm Covid-19 Vaccine (Bbibp-Corv) Exposure: A Series of Clinical Cases and Updated Review of the Literature, Current Journal of Neurology (2024)
11. A Comparative Study on the Effectiveness of Topiramate and Propranolol in Patients With Migraine With Aura, Current Journal of Neurology (2022)
12. Approach to a Patient With Headache, Headache and Migraine in Practice (2022)
13. Covid-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran, Vaccines (2022)
14. Headache and Migraine in Practice, Headache and Migraine in Practice (2022)
15. Medication Overuse Headache, Headache and Migraine in Practice (2022)
16. Medication Overuse Headache, Headache and Migraine in Practice (2022)
17. Trigeminal Autonomic Cephalalgia, Headache and Migraine in Practice (2022)
18. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
19. Pregnancy Outcome in Patients With Multiple Sclerosis Treated With Rituximab: A Case-Series Study, Multiple Sclerosis and Related Disorders (2021)
20. The Trend of Incidence, Prevalence, and Daly of Multiple Sclerosis in the Middle East and Northern Africa Region Compared to Global, West Europe And, Iran's Corresponding Values During 1990–2017: Retrieved From Global Burden of Diseases Data, Multiple Sclerosis and Related Disorders (2021)
21. Autoimmune Diseases Associated With Neuromyelitis Optica Spectrum Disorders: A Literature Review, Multiple Sclerosis and Related Disorders (2019)
22. Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (Adfc Study)-Two-Year Follow-Up Study, International Journal of Endocrinology (2018)
23. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
24. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
25. Risk Factors Associated With Diabetic Foot Ulcer-Free Survival in Patients With Diabetes, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2018)
26. Multiple Sclerosis and Environmental Risk Factors: A Case-Control Study in Iran, Neurological Sciences (2017)
27. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
28. Islamic Fasting and Multiple Sclerosis, BMC Neurology (2014)